Advanced search
Publication Cover
Current Medical Research and Opinion Volume 33, 2017 - Issue 1
Submit an article Journal homepage
504
Views
5
CrossRef citations to date
0
Altmetric
Cardiovascular

Social preference weights for treatments in Fabry disease in the UK: a discrete choice experiment

Andrew J. LloydBladon Associates Ltd., Oxford, UK; Correspondence[email protected]
,
Katy GallopBladon Associates Ltd., Bristol, UK;
,
Shehzad AliUniversity of York, York, UK;
,
Derralynn HughesRoyal Free Hospital, London, UK;
&
Alasdair MacCullochAmicus Therapeutics Ltd., London, UK
Pages 23-29 | Received 02 Aug 2016, Accepted 29 Aug 2016, Published online: 16 Sep 2016

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Domenico Moro, Michael Schlander, Harry Telser, Oriol Sola-Morales, Michael David Clark, Andrew Olaye, Charlotte Camp, Mohit Jain, Thomas Butt & Sumeet Bakshi. (2022) Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2]. Expert Review of Pharmacoeconomics & Outcomes Research 22:4, pages 581-598.
Read now

Articles from other publishers (4)

Ana Jovanovic, Eve Miller-Hodges, Felicia Castriota, Shweta Takyar, Heena Howitt & Olulade Ayodele. (2024) A systematic literature review on the health-related quality of life and economic burden of Fabry disease. Orphanet Journal of Rare Diseases 19:1.
Crossref
Louis S. Matza, Katie D. Stewart, Andrew J. Lloyd, Donna Rowen & John E. Brazier. (2021) Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations. Value in Health 24:6, pages 812-821.
Crossref
Vikas Soekhai, Esther W. de Bekker-Grob, Alan R. Ellis & Caroline M. Vass. (2018) Discrete Choice Experiments in Health Economics: Past, Present and Future. PharmacoEconomics 37:2, pages 201-226.
Crossref
Monica Hadi, Paul Swinburn, Luba Nalysnyk, Alaa Hamed & Atul Mehta. (2018) A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher disease. Orphanet Journal of Rare Diseases 13:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.